Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Paraganglioma × Phenoxybenzamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Pheochromocytoma 1 Paraganglioma 1

Interventions

3-Iodobenzylguanidine 3 pazopanib 1 lutetium Lu 177 dotatate 1 guadecitabine 1 gallium Ga 68 dotatate 1 copper dotatate CU-64 1 cabozantinib 1 atezolizumab 1 Radiosurgery 1 Phenoxybenzamine 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Doxazosin 1 Axitinib 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03176693 2023-11-20

Preoperative Alpha Blockade for Pheochromocytoma

University of California, Los Angeles

Phase 3 Completed

39 enrolled 8 charts

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡